WB28182 The effect of lebrikizumab in patients with severe asthma
Research type
Research Study
Full title
A phase II, randomised, double-blind, placebo-controlled, multicentre trial to assess the oral corticosteroid-sparing effect of lebrikizumab in patients with severe corticosteroid-dependant asthma
IRAS ID
102251
Contact name
Liam Heaney
Contact email
Sponsor organisation
F Hoffmann-La Roche Ltd
Eudract number
2012-000190-24
Clinicaltrials.gov Identifier
Research summary
Permission to publish the Research Summary not granted at this time
REC name
HSC REC B
REC reference
13/NI/0148
Date of REC Opinion
6 Nov 2013
REC opinion
Further Information Favourable Opinion